Ruxolitinib Cream Shows Promise for Hidradenitis Suppurativa Ruxolitinib Cream Shows Promise for Hidradenitis Suppurativa

Treatment with the topical JAK inhibitor reduced abscess and inflammatory nodules in a phase 2 randomized, controlled trial in patients with mild hidradenitis suppurativa.Medscape Medical News
Source: Medscape Dermatology Headlines - Category: Dermatology Tags: Dermatology Source Type: news